Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
Condition(s):Glioblastoma MultiformeLast Updated:February 23, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Glioblastoma MultiformeLast Updated:February 23, 2024Recruiting
Condition(s):Lung Cancer Stage I; Lung Cancer Stage II; Lung Cancer, Nonsmall Cell; Lung Cancer Recurrent; Lung Cancer Stage IVLast Updated:January 27, 2021Recruiting
Condition(s):Breast Cancer Female; Body Image DisturbanceLast Updated:June 13, 2019Terminated
Condition(s):Breast Cancer; Peripheral Neuropathy, Secondary to Drugs or ChemicalsLast Updated:October 9, 2019Completed
Condition(s):Hemophilia ALast Updated:February 3, 2017Completed
Condition(s):Non-small Cell Lung CancerLast Updated:August 31, 2018Terminated
Condition(s):Prostatic NeoplasmsLast Updated:March 18, 2022Terminated
Condition(s):Neoplasm MetastasesLast Updated:May 30, 2016Terminated
Condition(s):Prostatic NeoplasmsLast Updated:February 23, 2024Completed
Condition(s):Multiple Myeloma; LymphomaLast Updated:October 31, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.